Rebinyn

Indicated For

Hemophilia B

About This Medication

# Novo Nordisk Patient Assistance Program for Rebinyn® Patient Guide: How to Get Rebinyn® at Low or No Cost ## About This Guide This guide explains how to access **Rebinyn® (coagulation factor IX [recombinant], glycoPEGylated)** through Novo Nordisk's patient assistance programs. Rebinyn® is used to treat hemophilia B in adults and children for on-demand treatment, control of bleeding episodes, perioperative management, and routine prophylaxis to reduce bleeding frequency.[3] ## About Rebinyn® Rebinyn® is a recombinant coagulation factor IX therapy designed to help patients with hemophilia B manage their bleeding disorder. As a prescription medication, the cost can be significant, which is why Novo Nordisk offers multiple financial assistance options to help eligible patients access this treatment.[3] ## Financial Assistance Programs Available Novo Nordisk offers several programs through **NovoCare®** to help patients afford Rebinyn®:[2][3] - **Patient Assistance Program (PAP)**: Provides free medication to qualifying uninsured patients - **Co-pay Assistance Program**: Helps commercially insured patients reduce out-of-pocket costs up to $12,000 per calendar year - **Trial Prescription Program**: Offers a limited free supply to help patients transition to Rebinyn® - **Interim Product Program**: Provides hemophilia therapy during coverage gaps ## Who Qualifies ### Patient Assistance Program (PAP) The PAP is designed for **uninsured patients**.[7] To be eligible for the PAP in 2026, you must meet specific criteria set by Novo Nordisk. If you are eligible for Medicaid or Medicare LIS (Low Income Subsidy), you must submit a copy of your denial letter with your application.[1] **Important note:** Medicare Part D patients are generally not eligible for the PAP, though co-pay assistance may be available.[7] ### Co-pay Assistance Program This program is available to **commercially insured patients only**.[2] Eligibility and restrictions apply. The program can help reduce your out-of-pocket costs up to $12,000 per calendar year. ## Income Eligibility While specific income thresholds are not detailed in available program materials, Novo Nordisk evaluates eligibility based on individual financial circumstances. For patients who may qualify for Medicaid or Medicare LIS, documentation of denial is required with your application.[1] ## Insurance Requirements - **Uninsured patients**: Eligible for the Patient Assistance Program - **Commercially insured patients**: Eligible for co-pay assistance (up to $12,000 per year) - **Medicare Part D patients**: Generally not eligible for the PAP; co-pay assistance may be available - **Medicaid/Medicare LIS eligible patients**: Must provide denial letter with PAP application[1][7] ## How to Apply ### Step 1: Contact NovoCare® Reach out to NovoCare® to discuss your situation and learn which program best fits your needs: **Phone:** 1-844-668-6732[2][3] NovoCare® representatives can answer questions about eligibility, help verify your benefits, and guide you through the application process. Spanish-speaking representatives are available.[3] ### Step 2: Complete Your Application You will need to complete a patient application with supporting documentation. Your healthcare provider will also need to complete their portion of the application, so have your doctor's email address ready.[1] ### Step 3: Submit Required Documentation While specific documentation requirements vary by program, be prepared to provide: - Proof of income (if applicable) - Insurance information (or proof of being uninsured) - If eligible for Medicaid or Medicare LIS: a copy of your denial letter[1] - Healthcare provider information and prescription details ### Step 4: Await Approval Once your application is submitted with all supporting documentation and required fields completed, it will be processed within **2 business days**.[1] Any missing or incomplete information may cause a delay. ### Step 5: Receive Your Medication If your application is approved, you will receive a letter in the mail. If you selected automated phone alerts during your application, you will also receive an automated phone or text message.[1] Your doctor will be contacted for a prescription. You can expect a call from **Neovance™ Specialty Pharmacy at 1-800-488-5908** to schedule delivery of your medicine to your home.[1] ## Timeline and Delivery - **Application processing:** 2 business days (with complete information) - **Approval notification:** Letter in mail; automated phone/text alerts available - **Medication delivery:** Neovance™ Specialty Pharmacy will contact you to schedule home delivery - **No registration or monthly fees** are required to participate in the programs.[1] ## What If Your Application Is Denied? If your application for the PAP is denied, you may still be eligible for: - **Co-pay Assistance Program** (if you have commercial insurance) - **Trial Prescription Program** (limited free supply) - **Interim Product Program** (during coverage gaps) Contact NovoCare® at 1-844-668-6732 to discuss alternative options and next steps.[3] ## Additional Support Beyond financial assistance, Novo Nordisk provides: - **Rare Blood Community Liaisons (RBCLs)**: One-on-one support including disease education, lifestyle information, and local event updates[9] - **Benefits Verification (QuickCheck™)**: Verification of your insurance coverage and confirmation of benefits[3] - **Educational Resources**: Tools and information to help you manage your hemophilia B[5] ## Important Reminders - **Do not share your Rebinyn® pen with other people**, even if the needle has been changed, as this may transmit serious infections.[1] - Program availability and eligibility are subject to change without notice. Novo Nordisk reserves the right to modify or cancel programs at any time. - Product availability is subject to change without notice. - All programs have eligibility restrictions and requirements. ## Contact Information **NovoCare® Patient Support:** - Phone: 1-844-668-6732[2][3] - Website: NovoCare.com - Hours: Available to assist with program information and enrollment **Neovance™ Specialty Pharmacy (for medication delivery):** - Phone: 1-800-488-5908[1] ## Disclaimer This guide provides general information about Novo Nordisk's patient assistance programs for Rebinyn® as of March 2026. Program details, eligibility requirements, and benefits are subject to change. For the most current and complete information, contact NovoCare® directly at 1-844-668-6732 or visit NovoCare.com. This guide is not a guarantee of eligibility or program enrollment. Always consult with your healthcare provider about your treatment options and financial assistance.

Program information last verified: March 30, 2026